Literature DB >> 721586

[Antibiotic prophylaxis in intensive care].

F Daschner.   

Abstract

Of 611 prospectively studied patients in a surgical intensive care unit, 177 developed hospital infections (29%): urinary tract infections (37.2%), pneumonia (22.5%), sepsis (19.7%), wound infections (9.6%), etc. The commonest pathogens were Pseud. aeruginosa, E. coli, Staph. aureus, enterococci, Klebsiella pneumoniae and Proteus mirabilis. In preventing and combating hospital infections in intensive care units, priority should be given not to antibiotics but to hygiene in the hospital. Systemic antibiotic prophylaxis prevents neither hospital-contracted pneumonia, sepsis nor urinary tract infections. There is an urgent need for controlled studies on the necessity and selection of locally active antibacterial and antimycotic substances to prevent germ ascension in vein and bladder catheters.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 721586

Source DB:  PubMed          Journal:  Helv Chir Acta        ISSN: 0018-0181


  4 in total

1.  Polyvalent immunoglobulins for prophylaxis of bacterial infections in patients following multiple trauma. A randomized, placebo-controlled study.

Authors:  W Glinz; P J Grob; U E Nydegger; T Ricklin; F Stamm; D Stoffel; A Lasance
Journal:  Intensive Care Med       Date:  1985       Impact factor: 17.440

2.  The effect of selective decontamination of the digestive tract on colonisation and infection rate in multiple trauma patients.

Authors:  C P Stoutenbeek; H K van Saene; D R Miranda; D F Zandstra
Journal:  Intensive Care Med       Date:  1984       Impact factor: 17.440

3.  Nosocomial infections in intensive care wards: a multicenter prospective study.

Authors:  F D Daschner; P Frey; G Wolff; P C Baumann; P Suter
Journal:  Intensive Care Med       Date:  1982-01       Impact factor: 17.440

4.  [Perioperative antibiotic therapy--clinical experiences with a combination of mezlocillin/sisomicin in accident surgery].

Authors:  E Lais
Journal:  Unfallchirurgie       Date:  1984-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.